Research across borders

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find studies Explore world registries Peptide directory

Find a study

Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.

Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 21:55 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase 2TerminatedINTERVENTIONAL

Use of a Calcium Channel Blocker to Prevent Premature Luteinizing Hormone Surges in Infertility Patients

ClinicalTrials.gov · NCT01551368 · Registry updated: 2019-03-08

Condition / research focus: Infertility
Sponsor: Mount Sinai Hospital, Canada
Countries with listed sites: Canada
Registry dates and results: Start: 2012-12. Completion: 2017-07 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Nimodipine (drug) — also listed as: Nimotop
Placebo (drug) — also listed as: placebo tablets

Where the study takes place — 1 listed sites

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

Toronto Centre for Advanced reproductive Technology (TCART)
Toronto, Ontario, Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Infectious Pathogens in Acute Respiratory Illness in Adults and Elderly

ClinicalTrials.gov · NCT01360398 · Registry updated: 2019-02-15

Condition / research focus: Respiratory Disorders
Sponsor: GlaxoSmithKline
Countries with listed sites: United Kingdom
Registry dates and results: Start: 2011-06-30. Completion: 2014-06-27 (may be estimated). Results are posted in this registry.

Products and interventions (7)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Blood sample (procedure)
Sputum sample (procedure)
Nasopharyngeal swab (procedure)
Urine sample (procedure)
End tidal breath sample (procedure)
Data collection (other)
Tests (other)

Where the study takes place — 1 listed sites

GSK Investigational Site
Southampton, Hampshire, United Kingdom
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

RESCUE PROTOCOL AND FRESH EMBRYO TRANSFER

ClinicalTrials.gov · NCT03837223 · Registry updated: 2019-02-12

Condition / research focus: GnRH Trigger and Rescue Protocol
Sponsor: Istituto Clinico Humanitas
Countries with listed sites: No country reported
Registry dates and results: Start: 2013-03-01. Completion: 2016-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

GnRH agonist (drug) — also listed as: GnRH trigger

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Intrauterine Insemination Predictor Factors

ClinicalTrials.gov · NCT03836118 · Registry updated: 2019-02-11

Condition / research focus: Infertility
Sponsor: Istituto Clinico Humanitas
Countries with listed sites: Italy
Registry dates and results: Start: 1997-01-01. Completion: 2018-08-31 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Homologous intrauterine insemination (IUI) (procedure)

Where the study takes place — 1 listed sites

Paolo Emanuele Levi Setti
Rozzano, MI, Italy
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2 / Phase 3CompletedINTERVENTIONAL

Mapping the Endocrine Determinants of Ovarian Stimulation to Optimize Outcomes in Fresh Embryo Transfer Cycles

ClinicalTrials.gov · NCT02939898 · Registry updated: 2019-02-05

Condition / research focus: Infertility
Sponsor: Sven O. Skouby
Countries with listed sites: Denmark
Registry dates and results: Start: 2016-08. Completion: 2018-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Placebo (drug) — also listed as: Lactose Monohydrate
Letrozole (drug) — also listed as: Aromatase Inhibitor

Where the study takes place — 1 listed sites

Unit of Reproductive Medicine, Herlev Hospital
Herlev, Capital Region, Denmark
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

GnRH Agonist Versus hCG Trigger in Ovulation Induction With Intrauterine Insemination.

ClinicalTrials.gov · NCT03825445 · Registry updated: 2019-01-31

Condition / research focus: Ovulation Induction
Sponsor: Hue University of Medicine and Pharmacy
Countries with listed sites: No country reported
Registry dates and results: Start: 2016-04-01. Completion: 2017-06-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

GnRHa (Fertipeptil 0.1mg) (drug)
hCG (Pregnyl 5000IU) (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase not reported / not applicableTerminatedOBSERVATIONAL

Beta-hCG Test Reference Range Determination

ClinicalTrials.gov · NCT03485313 · Registry updated: 2019-01-25

Condition / research focus: Healthy
Sponsor: Response Biomedical Corp.
Countries with listed sites: Canada
Registry dates and results: Start: 2018-04-25. Completion: 2018-08-29 (may be estimated). No results posted in this registry response.

Products and interventions (0)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Where the study takes place — 1 listed sites

Response Biomedical Corp.
Vancouver, British Columbia, Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Timing of HCG Administration in IUI Cycles

ClinicalTrials.gov · NCT02330705 · Registry updated: 2019-01-25

Condition / research focus: Infertility
Sponsor: Mohamed Ibrahem Eid
Countries with listed sites: Egypt
Registry dates and results: Start: 2015-01. Completion: 2019-08 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

HCG (drug) — also listed as: Pregnyl

Where the study takes place — 2 listed sites

Fertility care unit (FCU) in Mansoura University Hospitals
Al Mansurah, Dakahlia Governorate, Egypt
Site recruitment: Recruiting
Private fertility care centers
Al Mansurah, Dakahlia Governorate, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Prospective Randomized Trial Comparing Corifollitropin-alfa Late Start vs. Corifollitropin-alfa Standard Start in Expected Poor, Normal and High-responders Undergoing IVF

ClinicalTrials.gov · NCT03816670 · Registry updated: 2019-01-25

Condition / research focus: Fertility Disorders
Sponsor: University of Turin, Italy
Countries with listed sites: Italy
Registry dates and results: Start: 2017-04-01. Completion: 2018-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Corifollitropin Alfa (drug)

Where the study takes place — 1 listed sites

Physiopathology of Reproduction and IVF Unit, S. Anna Hospital
Torino, Italy
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

The Effectiveness and Safety of the Prolonged Down-regulation Protocol for Controlled Ovarian Hyperstimulation

ClinicalTrials.gov · NCT03809221 · Registry updated: 2019-01-18

Condition / research focus: Infertility, Female
Sponsor: Peking University People's Hospital
Countries with listed sites: No country reported
Registry dates and results: Start: 2019-02-01. Completion: 2020-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Triptorelin acetate (drug) — also listed as: recombinant follicular stimulating hormone (rFSH), recombinant luteinizing hormone (rLH), urinanry human postmenopausal gonadotropin (HMG)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Intrauterine Injection of Human Chorionic Gonadotropin Injection (hCG) Before Frozen Embryo Transfer on Cycle Outcomes

ClinicalTrials.gov · NCT02355925 · Registry updated: 2018-12-28

Condition / research focus: Infertility
Sponsor: Royan Institute
Countries with listed sites: Iran
Registry dates and results: Start: 2014-10. Completion: 2018-12 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

intrauterine injection of uhCG (drug)
Placebo (drug)
control (other)

Where the study takes place — 1 listed sites

Royan Institute
Tehran, Iran
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Intrauterine Injection of Human Chorionic Gonadotropin Injection (hCG) Before Embryo Transfer on Pregnancy Outcomes in Frozen Embryo Transfer Cycles.

ClinicalTrials.gov · NCT02825108 · Registry updated: 2018-12-28

Condition / research focus: Infertility
Sponsor: Royan Institute
Countries with listed sites: Iran
Registry dates and results: Start: 2015-01. Completion: 2018-12 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Intra uterine injection of tissue culture medium containing HCG+ET (drug)
Intra uterine injection of tissue culture medium +ET (drug)
ET (procedure)

Where the study takes place — 1 listed sites

Royan Institute
Tehran, Iran
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3UnknownINTERVENTIONAL

Evaluation of Different Luteal Phase Support Methods in Patients With Poor Ovarian Response

ClinicalTrials.gov · NCT02798653 · Registry updated: 2018-12-27

Condition / research focus: Infertility
Sponsor: Royan Institute
Countries with listed sites: Iran
Registry dates and results: Start: 2015-11. Completion: 2019-12 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Choriomon® injection (drug)
Choriomon® injection+Endometrin ® (drug)
Endometrin ® vaginal tablets (drug)

Where the study takes place — 1 listed sites

Royan Institute
Tehran, Iran
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Cabergoline Versus Calcium Gluconate Infusion in the Prevention of Ovarian Hyperstimulation Syndrome

ClinicalTrials.gov · NCT02875587 · Registry updated: 2018-12-27

Condition / research focus: OHSS
Sponsor: Aljazeera Hospital
Countries with listed sites: Egypt
Registry dates and results: Start: 2016-10. Completion: 2018-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Cabergoline (drug)
Calcium gluconate (drug)

Where the study takes place — 2 listed sites

Aljazeera hospital
Giza, Egypt
Site recruitment: Not reported
Riyadh Fertility and Reproductive Health center
Giza, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Intrauterine G-CSF Administration in RIF

ClinicalTrials.gov · NCT03783208 · Registry updated: 2018-12-24

Condition / research focus: Infertility
Sponsor: Gurgan Clinic
Countries with listed sites: Turkey (Türkiye)
Registry dates and results: Start: 2018-11-01. Completion: 2018-12-20 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

G-CSF (drug) — also listed as: Leucostim
Saline (other)

Where the study takes place — 1 listed sites

Gurgan Clinic IVF and Women Health Center
Ankara, Cankaya, Turkey (Türkiye)
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Trans-vaginal Aspiration of Small Ovarian Endometrioma. Comparison of Two Different Techniques Before ICSI

ClinicalTrials.gov · NCT03784404 · Registry updated: 2018-12-21

Condition / research focus: Ovarian Endometrioma
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2018-12. Completion: 2019-12 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Transvaginal aspiration (procedure)
transvaginal aspiration and surgicel injection (procedure)
Intracytoplasmic sperm injection (drug)

Where the study takes place — 1 listed sites

Kasr Alainy medical school
Cairo, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Efficacy of Corifollitropin Alfa in Obese Women in Terms of Clinical and Molecular Parameters of IVF Success

ClinicalTrials.gov · NCT02606500 · Registry updated: 2018-11-26

Condition / research focus: Obesity
Sponsor: University Medical Centre Ljubljana
Countries with listed sites: Slovenia
Registry dates and results: Start: 2016-03. Completion: 2017-03 (may be estimated). Results are posted in this registry.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Elonva (drug)

Where the study takes place — 1 listed sites

Division of gynecology, Department of human reproduction
Ljubljana, Slovenia
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Theca Cell Function in Women With Polycystic Ovary Syndrome (PCOS)

ClinicalTrials.gov · NCT00747617 · Registry updated: 2018-11-21

Condition / research focus: Polycystic Ovary Syndrome
Sponsor: University of California, San Diego
Countries with listed sites: United States
Registry dates and results: Start: 2007-09. Completion: 2010-09 (may be estimated). Results are posted in this registry.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

recombinant human chorionic gonadotropin (drug) — also listed as: Ovidrel

Where the study takes place — 1 listed sites

University of California, San Diego, School of Medicine
La Jolla, California, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4TerminatedINTERVENTIONAL

Gene Expression Profile After Gonadotropin Releasing Hormone (GnRH) Agonist Trigger of Oocyte Maturation

ClinicalTrials.gov · NCT01606709 · Registry updated: 2018-11-21

Condition / research focus: Endometrial Receptivity; Ovarian Hyperstimulation Syndrome
Sponsor: UConn Health
Countries with listed sites: United States
Registry dates and results: Start: 2012-04. Completion: 2014-12 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

GnRH agonist (drug) — also listed as: leuprolide acetate,, lupron
hCG (drug) — also listed as: Pregnyl

Where the study takes place — 1 listed sites

UCHC Division of Reproductive Endocrinology
Farmington, Connecticut, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableTerminatedINTERVENTIONAL

Resolution of Uncertainty Through Testing

ClinicalTrials.gov · NCT03179059 · Registry updated: 2018-11-14

Condition / research focus: Pregnancy Tests
Sponsor: University of Illinois at Urbana-Champaign
Countries with listed sites: Uganda
Registry dates and results: Start: 2017-09-28. Completion: 2017-12-02 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Pregnancy test at Baseline (diagnostic_test)
Pregnancy test at follow up survey (diagnostic_test)

Where the study takes place — 1 listed sites

Ichuli Institute
Kampala, Uganda
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Explore the world’s study registries

These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.

Worldwide

Africa

Pan African Clinical Trial Registry ↗

Americas

Asia

Middle East

Europe

Oceania

Australia / New Zealand — ANZCTR ↗

Registry directory checked October 5, 2026 against the WHO registry network. This is a starting point, not complete coverage of every country or continent. Record availability, language and update schedules vary by registry.

Worldwide Study Finder

Loading registry information…

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find a study

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 21:55 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase 2TerminatedINTERVENTIONAL

Use of a Calcium Channel Blocker to Prevent Premature Luteinizing Hormone Surges in Infertility Patients

ClinicalTrials.gov · NCT01551368 · Registry updated: 2019-03-08

Condition / research focus: Infertility
Sponsor: Mount Sinai Hospital, Canada
Countries with listed sites: Canada
Registry dates and results: Start: 2012-12. Completion: 2017-07 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Nimodipine (drug) — also listed as: Nimotop
Placebo (drug) — also listed as: placebo tablets

Where the study takes place — 1 listed sites

Toronto Centre for Advanced reproductive Technology (TCART)
Toronto, Ontario, Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Infectious Pathogens in Acute Respiratory Illness in Adults and Elderly

ClinicalTrials.gov · NCT01360398 · Registry updated: 2019-02-15

Condition / research focus: Respiratory Disorders
Sponsor: GlaxoSmithKline
Countries with listed sites: United Kingdom
Registry dates and results: Start: 2011-06-30. Completion: 2014-06-27 (may be estimated). Results are posted in this registry.

Products and interventions (7)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Blood sample (procedure)
Sputum sample (procedure)
Nasopharyngeal swab (procedure)
Urine sample (procedure)
End tidal breath sample (procedure)
Data collection (other)
Tests (other)

Where the study takes place — 1 listed sites

GSK Investigational Site
Southampton, Hampshire, United Kingdom
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

RESCUE PROTOCOL AND FRESH EMBRYO TRANSFER

ClinicalTrials.gov · NCT03837223 · Registry updated: 2019-02-12

Condition / research focus: GnRH Trigger and Rescue Protocol
Sponsor: Istituto Clinico Humanitas
Countries with listed sites: No country reported
Registry dates and results: Start: 2013-03-01. Completion: 2016-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

GnRH agonist (drug) — also listed as: GnRH trigger

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Intrauterine Insemination Predictor Factors

ClinicalTrials.gov · NCT03836118 · Registry updated: 2019-02-11

Condition / research focus: Infertility
Sponsor: Istituto Clinico Humanitas
Countries with listed sites: Italy
Registry dates and results: Start: 1997-01-01. Completion: 2018-08-31 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Homologous intrauterine insemination (IUI) (procedure)

Where the study takes place — 1 listed sites

Paolo Emanuele Levi Setti
Rozzano, MI, Italy
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2 / Phase 3CompletedINTERVENTIONAL

Mapping the Endocrine Determinants of Ovarian Stimulation to Optimize Outcomes in Fresh Embryo Transfer Cycles

ClinicalTrials.gov · NCT02939898 · Registry updated: 2019-02-05

Condition / research focus: Infertility
Sponsor: Sven O. Skouby
Countries with listed sites: Denmark
Registry dates and results: Start: 2016-08. Completion: 2018-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Placebo (drug) — also listed as: Lactose Monohydrate
Letrozole (drug) — also listed as: Aromatase Inhibitor

Where the study takes place — 1 listed sites

Unit of Reproductive Medicine, Herlev Hospital
Herlev, Capital Region, Denmark
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

GnRH Agonist Versus hCG Trigger in Ovulation Induction With Intrauterine Insemination.

ClinicalTrials.gov · NCT03825445 · Registry updated: 2019-01-31

Condition / research focus: Ovulation Induction
Sponsor: Hue University of Medicine and Pharmacy
Countries with listed sites: No country reported
Registry dates and results: Start: 2016-04-01. Completion: 2017-06-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

GnRHa (Fertipeptil 0.1mg) (drug)
hCG (Pregnyl 5000IU) (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase not reported / not applicableTerminatedOBSERVATIONAL

Beta-hCG Test Reference Range Determination

ClinicalTrials.gov · NCT03485313 · Registry updated: 2019-01-25

Condition / research focus: Healthy
Sponsor: Response Biomedical Corp.
Countries with listed sites: Canada
Registry dates and results: Start: 2018-04-25. Completion: 2018-08-29 (may be estimated). No results posted in this registry response.

Products and interventions (0)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Where the study takes place — 1 listed sites

Response Biomedical Corp.
Vancouver, British Columbia, Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Timing of HCG Administration in IUI Cycles

ClinicalTrials.gov · NCT02330705 · Registry updated: 2019-01-25

Condition / research focus: Infertility
Sponsor: Mohamed Ibrahem Eid
Countries with listed sites: Egypt
Registry dates and results: Start: 2015-01. Completion: 2019-08 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

HCG (drug) — also listed as: Pregnyl

Where the study takes place — 2 listed sites

Fertility care unit (FCU) in Mansoura University Hospitals
Al Mansurah, Dakahlia Governorate, Egypt
Site recruitment: Recruiting
Private fertility care centers
Al Mansurah, Dakahlia Governorate, Egypt
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Prospective Randomized Trial Comparing Corifollitropin-alfa Late Start vs. Corifollitropin-alfa Standard Start in Expected Poor, Normal and High-responders Undergoing IVF

ClinicalTrials.gov · NCT03816670 · Registry updated: 2019-01-25

Condition / research focus: Fertility Disorders
Sponsor: University of Turin, Italy
Countries with listed sites: Italy
Registry dates and results: Start: 2017-04-01. Completion: 2018-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Corifollitropin Alfa (drug)

Where the study takes place — 1 listed sites

Physiopathology of Reproduction and IVF Unit, S. Anna Hospital
Torino, Italy
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

The Effectiveness and Safety of the Prolonged Down-regulation Protocol for Controlled Ovarian Hyperstimulation

ClinicalTrials.gov · NCT03809221 · Registry updated: 2019-01-18

Condition / research focus: Infertility, Female
Sponsor: Peking University People's Hospital
Countries with listed sites: No country reported
Registry dates and results: Start: 2019-02-01. Completion: 2020-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Triptorelin acetate (drug) — also listed as: recombinant follicular stimulating hormone (rFSH), recombinant luteinizing hormone (rLH), urinanry human postmenopausal gonadotropin (HMG)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Intrauterine Injection of Human Chorionic Gonadotropin Injection (hCG) Before Frozen Embryo Transfer on Cycle Outcomes

ClinicalTrials.gov · NCT02355925 · Registry updated: 2018-12-28

Condition / research focus: Infertility
Sponsor: Royan Institute
Countries with listed sites: Iran
Registry dates and results: Start: 2014-10. Completion: 2018-12 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

intrauterine injection of uhCG (drug)
Placebo (drug)
control (other)

Where the study takes place — 1 listed sites

Royan Institute
Tehran, Iran
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Intrauterine Injection of Human Chorionic Gonadotropin Injection (hCG) Before Embryo Transfer on Pregnancy Outcomes in Frozen Embryo Transfer Cycles.

ClinicalTrials.gov · NCT02825108 · Registry updated: 2018-12-28

Condition / research focus: Infertility
Sponsor: Royan Institute
Countries with listed sites: Iran
Registry dates and results: Start: 2015-01. Completion: 2018-12 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Intra uterine injection of tissue culture medium containing HCG+ET (drug)
Intra uterine injection of tissue culture medium +ET (drug)
ET (procedure)

Where the study takes place — 1 listed sites

Royan Institute
Tehran, Iran
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3UnknownINTERVENTIONAL

Evaluation of Different Luteal Phase Support Methods in Patients With Poor Ovarian Response

ClinicalTrials.gov · NCT02798653 · Registry updated: 2018-12-27

Condition / research focus: Infertility
Sponsor: Royan Institute
Countries with listed sites: Iran
Registry dates and results: Start: 2015-11. Completion: 2019-12 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Choriomon® injection (drug)
Choriomon® injection+Endometrin ® (drug)
Endometrin ® vaginal tablets (drug)

Where the study takes place — 1 listed sites

Royan Institute
Tehran, Iran
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Cabergoline Versus Calcium Gluconate Infusion in the Prevention of Ovarian Hyperstimulation Syndrome

ClinicalTrials.gov · NCT02875587 · Registry updated: 2018-12-27

Condition / research focus: OHSS
Sponsor: Aljazeera Hospital
Countries with listed sites: Egypt
Registry dates and results: Start: 2016-10. Completion: 2018-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Cabergoline (drug)
Calcium gluconate (drug)

Where the study takes place — 2 listed sites

Aljazeera hospital
Giza, Egypt
Site recruitment: Not reported
Riyadh Fertility and Reproductive Health center
Giza, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Intrauterine G-CSF Administration in RIF

ClinicalTrials.gov · NCT03783208 · Registry updated: 2018-12-24

Condition / research focus: Infertility
Sponsor: Gurgan Clinic
Countries with listed sites: Turkey (Türkiye)
Registry dates and results: Start: 2018-11-01. Completion: 2018-12-20 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

G-CSF (drug) — also listed as: Leucostim
Saline (other)

Where the study takes place — 1 listed sites

Gurgan Clinic IVF and Women Health Center
Ankara, Cankaya, Turkey (Türkiye)
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Trans-vaginal Aspiration of Small Ovarian Endometrioma. Comparison of Two Different Techniques Before ICSI

ClinicalTrials.gov · NCT03784404 · Registry updated: 2018-12-21

Condition / research focus: Ovarian Endometrioma
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2018-12. Completion: 2019-12 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Transvaginal aspiration (procedure)
transvaginal aspiration and surgicel injection (procedure)
Intracytoplasmic sperm injection (drug)

Where the study takes place — 1 listed sites

Kasr Alainy medical school
Cairo, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Efficacy of Corifollitropin Alfa in Obese Women in Terms of Clinical and Molecular Parameters of IVF Success

ClinicalTrials.gov · NCT02606500 · Registry updated: 2018-11-26

Condition / research focus: Obesity
Sponsor: University Medical Centre Ljubljana
Countries with listed sites: Slovenia
Registry dates and results: Start: 2016-03. Completion: 2017-03 (may be estimated). Results are posted in this registry.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Elonva (drug)

Where the study takes place — 1 listed sites

Division of gynecology, Department of human reproduction
Ljubljana, Slovenia
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Theca Cell Function in Women With Polycystic Ovary Syndrome (PCOS)

ClinicalTrials.gov · NCT00747617 · Registry updated: 2018-11-21

Condition / research focus: Polycystic Ovary Syndrome
Sponsor: University of California, San Diego
Countries with listed sites: United States
Registry dates and results: Start: 2007-09. Completion: 2010-09 (may be estimated). Results are posted in this registry.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

recombinant human chorionic gonadotropin (drug) — also listed as: Ovidrel

Where the study takes place — 1 listed sites

University of California, San Diego, School of Medicine
La Jolla, California, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4TerminatedINTERVENTIONAL

Gene Expression Profile After Gonadotropin Releasing Hormone (GnRH) Agonist Trigger of Oocyte Maturation

ClinicalTrials.gov · NCT01606709 · Registry updated: 2018-11-21

Condition / research focus: Endometrial Receptivity; Ovarian Hyperstimulation Syndrome
Sponsor: UConn Health
Countries with listed sites: United States
Registry dates and results: Start: 2012-04. Completion: 2014-12 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

GnRH agonist (drug) — also listed as: leuprolide acetate,, lupron
hCG (drug) — also listed as: Pregnyl

Where the study takes place — 1 listed sites

UCHC Division of Reproductive Endocrinology
Farmington, Connecticut, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableTerminatedINTERVENTIONAL

Resolution of Uncertainty Through Testing

ClinicalTrials.gov · NCT03179059 · Registry updated: 2018-11-14

Condition / research focus: Pregnancy Tests
Sponsor: University of Illinois at Urbana-Champaign
Countries with listed sites: Uganda
Registry dates and results: Start: 2017-09-28. Completion: 2017-12-02 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Pregnancy test at Baseline (diagnostic_test)
Pregnancy test at follow up survey (diagnostic_test)

Where the study takes place — 1 listed sites

Ichuli Institute
Kampala, Uganda
Site recruitment: Not reported

Original record, eligibility, contacts and results →